A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated
- PMID: 7908440
- PMCID: PMC43437
- DOI: 10.1073/pnas.91.7.2699
A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated
Abstract
The beta 2-adrenergic receptor (beta 2AR) can be constitutively activated by mutations in the third intracellular loop. Whereas the wild-type receptor exists predominantly in an inactive conformation (R) in the absence of agonist, the mutant receptor appears to spontaneously adopt an active conformation (R*). We now demonstrate that not only is the mutant beta 2AR constitutively active, it is also constitutively desensitized and down-regulated. To assess whether the mutant receptor can constitutively engage a known element of the cellular desensitization machinery, the receptor was purified and reconstituted into phospholipid vesicles. These preparations retained the essential properties of the constitutively active mutant receptor: agonist-independent activity [to stimulate guanine nucleotide-binding protein (Gs)-GTPase] and agonist-specific increase in binding affinity. Moreover, the purified mutant receptor, in the absence of agonist, was phosphorylated by recombinant beta AR-specific kinase (beta ARK) in a fashion comparable to the agonist-occupied wild-type receptor. Thus, the conformation of the mutated receptor is equivalent to the active conformation (R*), which stimulates Gs protein and is identical to the beta ARK substrate.
Similar articles
-
Role of beta ARK in long-term agonist-promoted desensitisation of the beta 2-adrenergic receptor.Cell Signal. 1998 Mar;10(3):197-204. doi: 10.1016/s0898-6568(97)00112-5. Cell Signal. 1998. PMID: 9607143
-
Stable association of G proteins with beta 2AR is independent of the state of receptor activation.Cell Signal. 1999 Jul;11(7):523-33. doi: 10.1016/s0898-6568(99)00024-8. Cell Signal. 1999. PMID: 10405763
-
Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.Biochemistry. 1994 Aug 16;33(32):9414-9. doi: 10.1021/bi00198a006. Biochemistry. 1994. PMID: 7915137
-
Inverse agonism and the regulation of receptor number.Trends Pharmacol Sci. 1997 Dec;18(12):468-74. doi: 10.1016/s0165-6147(97)01139-5. Trends Pharmacol Sci. 1997. PMID: 9458695 Review.
-
Molecular and genetic basis of beta2-adrenergic receptor function.J Allergy Clin Immunol. 1999 Aug;104(2 Pt 2):S42-6. doi: 10.1016/s0091-6749(99)70272-1. J Allergy Clin Immunol. 1999. PMID: 10452787 Review.
Cited by
-
Structural studies of phosphorylation-dependent interactions between the V2R receptor and arrestin-2.Nat Commun. 2021 Apr 22;12(1):2396. doi: 10.1038/s41467-021-22731-x. Nat Commun. 2021. PMID: 33888704 Free PMC article.
-
Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor.Br J Pharmacol. 2001 May;133(2):315-23. doi: 10.1038/sj.bjp.0704077. Br J Pharmacol. 2001. PMID: 11350868 Free PMC article.
-
Comparison of the function of two novel human dopamine D2 receptor variants identifies a likely mechanism for their pathogenicity.Biochem Pharmacol. 2024 Oct;228:116228. doi: 10.1016/j.bcp.2024.116228. Epub 2024 Apr 21. Biochem Pharmacol. 2024. PMID: 38643909
-
The Open Question of How GPCRs Interact with GPCR Kinases (GRKs).Biomolecules. 2021 Mar 17;11(3):447. doi: 10.3390/biom11030447. Biomolecules. 2021. PMID: 33802765 Free PMC article.
-
Structural and functional characterization of G protein-coupled receptors with deep mutational scanning.Elife. 2020 Oct 21;9:e54895. doi: 10.7554/eLife.54895. Elife. 2020. PMID: 33084570 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials